Utility of (18)F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy

BACKGROUND: Pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) is a predictor of improved outcomes in breast cancer. In patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) -negative breast cancer, the response to NAC is variable and most...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: Lee, In Hee, Lee, Soo Jung, Lee, Jeeyeon, Jung, Jin Hyang, Park, Ho Yong, Jeong, Shin Young, Lee, Sang-woo, Chae, Yee Soo
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667770/
https://ncbi.nlm.nih.gov/pubmed/33198673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07505-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料